Table 2.
Difference in current practice and a no screening trial strategy for the year 2019/20.
| Current practice | No screening trial | |
|---|---|---|
| No. patients with SCS | 576 | 576 |
| No. patients with a screening trial | 576 | - |
| No. patients with unsuccessful screening trial | 61 | - |
| SCS device costs | £8,967,511 | £10,035,072 |
| SCS implant costs | £1,995,620 | £2,233,194 |
| Screening trial costs | £1,547,520 | - |
| Unsuccessful screening trial costs | £161,009 | - |
| Total | £12,671,660 | £12,268,266 |
| Cost difference | £403,394 | |
| Cost difference per patient | £700 | |
SCS, spinal cord stimulation.